0 results for 'Robbins Geller Rudman amp Dowd LLP'
'I Think You Are a Bad Human Being': Elon Musk Fires Back at Investors' Lawyer From Witness Stand
Questioning from both sides Monday morning boiled down to establishing context in two areas: Tesla's place in the world of solar power and Musk's role within Tesla, primarily with regard to his level of control in relation to directors.Musk to Tesla Investors' Attorney: 'I Think You Are a Bad Human Being'
Questioning from both sides Monday morning boiled down to establishing context in two areas: Tesla's place in the world of solar power and Musk's role within Tesla, primarily with regard to his level of control in relation to directors.Trial Starts Today in Investor Suit Targeting Elon Musk and Tesla
The derivative complaint alleged that Elon Musk breached his fiduciary duties and unjustly enriched himself by pursuing the struggling SolarCity, in which he was the largest investor.Trial Set to Begin in Investor Suit Targeting Elon Musk Over $2.6B SolarCity Deal
The derivative complaint alleged that Elon Musk breached his fiduciary duties and unjustly enriched himself by pursuing the struggling SolarCity, in which he was the largest investor.View more book results for the query "Robbins Geller Rudman amp Dowd LLP"
Trial for Investor Suit Targeting Elon Musk Over $2.6B SolarCity Deal Set to Begin
The derivative complaint alleged that Elon Musk breached his fiduciary duties and unjustly enriched himself by pursuing the struggling SolarCity, in which he was the largest investor.Trial for Investor Suit Targeting Elon Musk Over $2.6B SolarCity Deal Set to Begin
The derivative complaint alleged that Elon Musk breached his fiduciary duties and unjustly enriched himself by pursuing the struggling SolarCity, in which he was the largest investor.EpiPen Class Action Heads to Trial on Curtailed Antitrust Claim
U.S. District Judge Daniel Crabtree in June tossed claims brought under the U.S. Racketeer Influenced and Corrupt Organizations Act and some of the antitrust allegations against Mylan Pharmaceuticals, which sold the EpiPen, a pen-like device that treats anaphylaxis, a potentially fatal condition caused by food allergies and insect bites. Trial is set for Sept. 7.Health Care Company Missed 'Red Flags' Before Breach Affected Millions, Class Action Claims
This suit was surfaced by Law.com Radar. Read the complaint here.Who's Really to Blame for Dozing and Distracted Jurors?: The Morning Minute
The news and analysis you need to start your day.Trending Stories
Insights and Strategies for Effective Succession Planning in AM Law 100 Firms
Brought to you by Gallagher
Download Now
State AI Legislation Is on the Move in 2024
Brought to you by LexisNexis®
Download Now
2024 ESI Risk Management & Litigation Readiness Report
Brought to you by Pagefreezer
Download Now
Creating a Culture of Compliance
Brought to you by Ironclad
Download Now